GCL
LVACW

Glazer Capital LLC’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

Glazer Capital LLC’s Portfolio LVACW Stock Details LVACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-279
Closed – – 751
2022
Q2 		$0 Sell
279
-14,200
-98% -$2.9K ﹤0.01% 790
2022
Q1 		$5K Buy
+14,479
New +$5.87K ﹤0.01% 540

Other funds holding LVACW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.48% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

Glazer Capital LLC's LVACW Position: Q3 2022 in Review

Glazer Capital LLC sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q3 2022, closing a stake of 279 shares.

Glazer Capital LLC first reported a position in LVACW in Q1 2022 and held it in 2 quarters. The position peaked at $5K in Q1 2022. 31 funds tracked by Wall St. Rank hold LVACW as of Q3 2022.

  • Glazer Capital LLC reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q3 2022 after selling out during the quarter.
  • Glazer Capital LLC sold 279 LAVA Medtech Acquisition Corp. Warrants shares in Q3 2022.
  • Glazer Capital LLC first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q1 2022 and held it in 2 quarters.
  • Glazer Capital LLC's LAVA Medtech Acquisition Corp. Warrants position peaked at $5K in Q1 2022.
  • 31 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q3 2022.

Based on Glazer Capital LLC's 13F filing for Q3 2022, filed 14 Nov 2022.